Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | GLA | P06280 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014129 | 0.85 | CYP2A6 (0.58) | CYP2A6MAOBAPPCA9PIM1 | |
| SCHEMBL11550694 | 0.78 | CYP2A6 (0.60) | CYP2A6MIFCA9MEN1KMT2A | |
| SCHEMBL21688681 | 0.77 | CYP2A6 (0.58) | CYP2A6APPMIFCA9MEN1 | |
| SCHEMBL21688675 | 0.77 | CYP2A6 (0.58) | CYP2A6MIFCA9MEN1KMT2A | |
| SCHEMBL26013326 | 0.77 | CYP2A6 (0.58) | CYP2A6MIFCA9MEN1KMT2A | |
| SCHEMBL7214706 | 0.77 | CA9 (0.60) | CYP2A6MIFCA9MEN1KMT2A | |
| SCHEMBL17182523 | 0.77 | CYP2A6 (0.53) | CYP2A6MAOBMIFCA9MEN1 | |
| SCHEMBL846924 | 0.74 | CYP2A6 (1.00) | CYP2A6MAOBCA9MEN1KMT2A | |
| SCHEMBL30142419 | 0.74 | CYP2A6 (1.00) | CYP2A6MAOBCA9MEN1KMT2A | |
| SCHEMBL11863201 | 0.73 | CYP2A6 (0.53) | CYP2A6APPMEN1KMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604326-B1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORP (JP) | 2026-01-07 | — | — | EP | disclosed |
| CN-110475785-B | Peptide compound, method for producing same, composition for screening, and method for selecting peptide compound | 富士胶片株式会社 | 2023-06-13 | — | — | CN | disclosed |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3604326-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-3604326-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| CN-110475785-A | The selection method of peptide compounds and its manufacturing method, screening composition and peptide compounds | FUJIFILM CORP | 2019-11-19 | — | — | CN | disclosed |
| WO-2013052263-A2 | ANTIFUNGAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013052263-A2 | ANTIFUNGAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013040528-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040528-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040526-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013040526-A1 | ANTIMICROBIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2013-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | CYP2A6 4664/4885MAOB 4806/4885APP 85/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | CYP2A6 4664/4885MAOB 4806/4885APP 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.